HOME > TOP STORIES

TOP STORIES

BUSINESS Drug Makers’ Specialty Care Pipelines Hit Snags in Late-Stage Development

January 21, 2013
ORGANIZATION JPMA Bolstering ICH Activities to Propose New Topics from Industry

January 18, 2013
BUSINESS Celgene K.K. Focused on MR Training Aiming for No. 1 Ranking Among Hematologists in 2013

January 18, 2013
BUSINESS OrphanPacific’s Orphan Drug Biz Faces Rough Going with Rising Costs

January 17, 2013
BUSINESS Domestic Drug Makers Working to Escape Dependence on Long-Listed Drugs through New Product Development

January 17, 2013
BUSINESS GMP Violations at Drug Substance Makers Prompt Series of New Voluntary Recalls of Generics; Stable Supplies Disrupted

January 16, 2013
ORGANIZATION JMA Vice Pres. Nakagawa Urges Pharmacies to Rigidly Check Medical Exam History of Epadel OTC Buyers

January 15, 2013
REGULATORY Focus May Be on Whether New Price Cutting Rule for Long-Listed Drugs Should Apply Only to Those Granted Premium

January 15, 2013
REGULATORY PMDA Probes How Insurance Pharmacies Utilize Drug Safety Information

January 11, 2013
BUSINESS Takeda to Pitch Lotriga for Patients with Residual Event Risks, Cultivate New Market

January 10, 2013
BUSINESS AbbVie to Focus on Specialty Care, “Not Interested” in Established Markets: CEO Winer

January 9, 2013
ORGANIZATION Efforts to Promote Generic Substitution Preferable to Cutting Prices of Long-Listed Drugs: Mr Sawai of JGA

January 8, 2013
BUSINESS “Appropriate Expressions” of Disease Awareness Ads Being Tested

January 7, 2013
ORGANIZATION Member Companies to Begin Enforcing New COP in FY2013: JPMA President Teshirogi

January 7, 2013
ORGANIZATION NHO to Review Calculation Method for Clinical Trial Costs

December 28, 2012
REGULATORY 2nd Abe Cabinet Inaugurated; Industry Awaits Decision on Perpetuation of Premium for New Drug Development

December 27, 2012
REGULATORY LDP to Finalize Tax Reform Outline for FY2013 by Late January

December 26, 2012
ORGANIZATION JMA to Discuss JPMA’s Transparency Guidelines with JPMA, Related Medical Organizations

December 25, 2012
REGULATORY MHLW to Establish a Venue for Discussions to Review Policies for OTC Switching of Lifestyle Disease Treatments

December 21, 2012
REGULATORY Osaka’s Healthcare Plan Highlights Differences in Definition of “Frequent Deliveries”

December 21, 2012

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

MHLW Floats Deducting Private-Practice Use for Re-Pricing, but Off-Cycle Cuts Possible; GLP-1 Eyed?

Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…

COLUMN

AI in HR: Navigating the Ethical Minefield

By Philip Carrigan

Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…